Bharat Biotech's Covaxin gets approval from the Drug Controller General of India (DGCI) for emergency use for children aged between 12-18 years. from Medindia Health News https://ift.tt/3mWAw8f
No comments
Thanks for comment via will connect you within 24 hours.